Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Star
642.0500 1.40 (0.22%)
NSE Jun 06, 2025 15:31 PM
Volume: 1.7M
 

logo
Laurus Labs Ltd.
25 Jan 2025
642.05
0.22%
Motilal Oswal
Laurus Lab (LAURUS) significantly beat our earnings estimates in 3QFY25, led by a scale-up in the CDMO segment. Commercial supplies (including launch quantities) led to strong 89% YoY growth in CDMO sales for the quarter.
Number of FII/FPI investors increased from 237 to 259 in Mar 2025 qtr.
More from Laurus Labs Ltd.
Recommended